A0868 - Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy
Roa, F.J., Roubelakis, M.G., Paschidis, K., Van Creij, N.C.H., Makridakis, M., Tserga, A., Vlahou, A., Santer, F.R., Holm, P.S., Hoffmann, M.J., Puhr, M., Mokou, M., Frantzi, M., Latosinska, A., Mischak, H., Culig, Z., Pichler, R.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy
Roa, F.J., Roubelakis, M.G., Paschidis, K., Van Creij, N.C.H., Makridakis, M., Tserga, A., Vlahou, A., Santer, F.R., Holm, P.S., Hoffmann, M.J., Puhr, M., Mokou, M., Frantzi, M., Latosinska, A., Mischak, H., Culig, Z., Pichler, R.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
Role of mitochondrial dynamics in tumorigenic potential and docetaxel resistance in prostate cancer
Roa, F.J., González, I., Savic, D., Van Goubergen, J., Santer, F.R., Puhr, M., Toledo, J.R., Skvortsova, I., Culig, Z., Klocker, H.
Published in European urology open science (Online) (01.10.2022)
Published in European urology open science (Online) (01.10.2022)
Get full text
Journal Article
237 The multikinase inhibitor sorafenib suppresses AR expression and signaling and induces apoptosis of castration therapy-resistant prostate cancer cells
Oh, S.J, Erb, H, Hobisch, A, Santer, F.R, Culig, Z
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)
Get full text
Journal Article
942 TYROSINE KINASE INHIBITOR SORAFENIB INDUCES GROWTH INHIBITION AND APOPTOSIS OF HUMAN PROSTATE CANCER CELLS BY REGULATION OF CELL CYCLE AND CELL DEATH CONTROLLING PROTEINS AND BLOCKING OF THE AKT PATHWAY
Oh, S.J, Santer, F.R, Erb, H, Cavarretta, I.T, Hobisch, A, Culig, Z
Published in European urology supplements : official journal of the European Association of Urology (2011)
Published in European urology supplements : official journal of the European Association of Urology (2011)
Get full text
Journal Article
P17 - p300 and CBP targeting in castration therapy resistant prostate cancer
Furlan, T., Kirchmair, A., Sampson, N., Puhr, M., Gruber, M., Trajanoski, Z., Santer, F.R., Culig, Z.
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Get full text
Journal Article
p300 and CBP targeting in castration therapy resistant prostate cancer
Furlan, T., Kirchmair, A., Sampson, N., Puhr, M., Gruber, M., Trajanoski, Z., Santer, F.R., Culig, Z.
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Get full text
Journal Article
P36 - p300 up-regulation by docetaxel contributes to chemotherapy resistance in prostate cancer
Gruber, M., Ferrone, L., Schäfer, G., Santer, F.R., Furlan, T., Eder, I., Sampson, N., Puhr, M., Handle, F., Culig, Z.
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Get full text
Journal Article
p300 up-regulation by docetaxel contributes to chemotherapy resistance in prostate cancer
Gruber, M., Ferrone, L., Schäfer, G., Santer, F.R., Furlan, T., Eder, I., Sampson, N., Puhr, M., Handle, F., Culig, Z.
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Get full text
Journal Article